Clinical Trial Update: A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of an investigational drug for schizophrenia in acutely psychotic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED